Physician profile
Pearon G Lang
NPI 1104854314
$3,072.13
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,515 · 2020: $505 · 2021: $383 · 2022: $648 · 2023: $21.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $482.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $460.48 | 2019-2023 | |
| Genzyme Corporation | $261.39 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $252.03 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $205.74 | 2019-2022 | |
| Lilly USA, LLC | $192.24 | 2019-2020 | |
| Amgen INC. | $178.11 | 2019-2021 | |
| Pfizer INC. | $169.69 | 2019-2022 | |
| Janssen Biotech, INC. | $145.11 | 2019-2020 | |
| Celgene Corporation | $140.23 | 2019 | |
| Ucb, INC. | $118.42 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $107.46 | 2019-2021 | |
| Genentech USA, INC. | $83.48 | 2019 | |
| Vyne Pharmaceuticals INC. | $35.53 | 2020 | |
| Mayne Pharma Commercial LLC | $34.95 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $33.55 | 2019-2022 | |
| Aclaris Therapeutics, INC. | $28.11 | 2019 | |
| Almirall LLC | $21.84 | 2019 | |
| Kyowa Kirin, INC. | $21.56 | 2019 | |
| Dermira, INC. | $18.33 | 2020 | |
| Epi Health, LLC | $17.66 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.42 | 2021 | |
| Incyte Corporation | $16.23 | 2022 | |
| Biofrontera INC. | $13.67 | 2019 | |
| Galderma Laboratories, L.P. | $11.55 | 2019 | |
| Prugen, INC. Pharmaceuticals | $5.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pearon Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.